RELATIONSHIP BETWEEN PHARMACOKINETICS AND BIOAVAILABILITY OF CEFROXADINE (CGP-9000) AND RENAL-FUNCTION

被引:3
作者
BERGAN, T [1 ]
BRODWALL, EK [1 ]
LARSEN, EW [1 ]
机构
[1] UNIV OSLO,RIKSHOSP,DEPT MED B,OSLO,NORWAY
关键词
D O I
10.1159/000238192
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:163 / 173
页数:11
相关论文
共 8 条
[1]  
BERGAN T, 1981, METHOD FIND EXP CLIN, V3, P179
[2]   PHARMACOKINETICS OF A NEW CEPHALOSPORIN, CEFOTAXIME (HR-756) IN PATIENTS WITH DIFFERENT RENAL FUNCTIONS [J].
BERGAN, T ;
LARSEN, EW ;
BRODWALL, EK .
CHEMOTHERAPY, 1982, 28 (02) :85-104
[3]  
BERGAN T, 1981, CHEMOTHERAPY, V127, P155
[4]  
BERGAN T, 1981, FUTURE ANTIBIOTHERAP, P219
[5]  
HOLT HA, 1978, 10TH P INT C CHEM, V2, P829
[6]  
MASHIMO K, 1980, 11TH INT C CHEM 19TH
[7]  
NAKAI Y, 1976, J ANTIBIOT TOKYO, V26, P81
[8]  
WAGNER JG, 1975, FUNDAMENTALS PHARMAC